Literature DB >> 27030262

B Cell Responses during Secondary Dengue Virus Infection Are Dominated by Highly Cross-Reactive, Memory-Derived Plasmablasts.

Lalita Priyamvada1, Alice Cho1, Nattawat Onlamoon2, Nai-Ying Zheng3, Min Huang3, Yevgeniy Kovalenkov1, Kulkanya Chokephaibulkit4, Nasikarn Angkasekwinai5, Kovit Pattanapanyasat2, Rafi Ahmed6, Patrick C Wilson3, Jens Wrammert7.   

Abstract

UNLABELLED: Dengue virus (DENV) infection results in the production of both type-specific and cross-neutralizing antibodies. While immunity to the infecting serotype is long-lived, heterotypic immunity wanes a few months after infection. Epidemiological studies link secondary heterotypic infections with more severe symptoms, and cross-reactive, poorly neutralizing antibodies have been implicated in this increased disease severity. To understand the cellular and functional properties of the acute dengue virus B cell response and its role in protection and immunopathology, we characterized the plasmablast response in four secondary DENV type 2 (DENV2) patients. Dengue plasmablasts had high degrees of somatic hypermutation, with a clear preference for replacement mutations. Clonal expansions were also present in each donor, strongly supporting a memory origin for these acutely induced cells. We generated 53 monoclonal antibodies (MAbs) from sorted patient plasmablasts and found that DENV-reactive MAbs were largely envelope specific and cross neutralizing. Many more MAbs neutralized DENV than reacted to envelope protein, emphasizing the significance of virion-dependent B cell epitopes and the limitations of envelope protein-based antibody screening. A majority of DENV-reactive MAbs, irrespective of neutralization potency, enhanced infection by antibody-dependent enhancement (ADE). Interestingly, even though DENV2 was the infecting serotype in all four patients, several MAbs from two patients neutralized DENV1 more potently than DENV2. Further, half of all type-specific neutralizing MAbs were also DENV1 biased in binding. Taken together, these findings are reminiscent of original antigenic sin (OAS), given that the patients had prior dengue virus exposures. These data describe the ongoing B cell response in secondary patients and may further our understanding of the impact of antibodies in dengue virus pathogenesis. IMPORTANCE: In addition to their role in protection, antibody responses have been hypothesized to contribute to the pathology of dengue. Recent studies characterizing memory B cell (MBC)-derived MAbs have provided valuable insight into the targets and functions of B cell responses generated after DENV exposure. However, in the case of secondary infections, such MBC-based approaches fail to distinguish acutely induced cells from the preexisting MBC pool. Our characterization of plasmablasts and plasmablast-derived MAbs provides a focused analysis of B cell responses activated during ongoing infection. Additionally, our studies provide evidence of OAS in the acute-phase dengue virus immune response, providing a basis for future work examining the impact of OAS phenotype antibodies on protective immunity and disease severity in secondary infections.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27030262      PMCID: PMC4886779          DOI: 10.1128/JVI.03203-15

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  53 in total

1.  Immunological enhancement of dengue virus replication.

Authors:  S B Halstead; J S Chow; N J Marchette
Journal:  Nat New Biol       Date:  1973-05-02

2.  A prospective study of dengue infections in Bangkok.

Authors:  D S Burke; A Nisalak; D E Johnson; R M Scott
Journal:  Am J Trop Med Hyg       Date:  1988-01       Impact factor: 2.345

3.  Complexity of Neutralizing Antibodies against Multiple Dengue Virus Serotypes after Heterotypic Immunization and Secondary Infection Revealed by In-Depth Analysis of Cross-Reactive Antibodies.

Authors:  Wen-Yang Tsai; Anna Durbin; Jih-Jin Tsai; Szu-Chia Hsieh; Stephen Whitehead; Wei-Kung Wang
Journal:  J Virol       Date:  2015-07       Impact factor: 5.103

4.  Risk factors in dengue shock syndrome.

Authors:  S Thein; M M Aung; T N Shwe; M Aye; A Zaw; K Aye; K M Aye; J Aaskov
Journal:  Am J Trop Med Hyg       Date:  1997-05       Impact factor: 2.345

5.  Dengue in the early febrile phase: viremia and antibody responses.

Authors:  D W Vaughn; S Green; S Kalayanarooj; B L Innis; S Nimmannitya; S Suntayakorn; A L Rothman; F A Ennis; A Nisalak
Journal:  J Infect Dis       Date:  1997-08       Impact factor: 5.226

6.  Original antigenic sin in dengue.

Authors:  S B Halstead; S Rojanasuphot; N Sangkawibha
Journal:  Am J Trop Med Hyg       Date:  1983-01       Impact factor: 2.345

7.  Antibody-dependent enhancement of dengue virus infection in U937 cells requires cholesterol-rich membrane microdomains.

Authors:  Henry Puerta-Guardo; Clemente Mosso; Fernando Medina; Ferdinando Liprandi; Juan E Ludert; Rosa María del Angel
Journal:  J Gen Virol       Date:  2009-10-14       Impact factor: 3.891

8.  Dengue and chikungunya virus infection in man in Thailand, 1962-1964. I. Observations on hospitalized patients with hemorrhagic fever.

Authors:  S Nimmannitya; S B Halstead; S N Cohen; M R Margiotta
Journal:  Am J Trop Med Hyg       Date:  1969-11       Impact factor: 2.345

9.  Kinetics of viremia and NS1 antigenemia are shaped by immune status and virus serotype in adults with dengue.

Authors:  Vianney Tricou; Nguyet Nguyen Minh; Jeremy Farrar; Hien Tinh Tran; Cameron P Simmons
Journal:  PLoS Negl Trop Dis       Date:  2011-09-06

Review 10.  The human antibody response to dengue virus infection.

Authors:  Wahala M P B Wahala; Aravinda M de Silva
Journal:  Viruses       Date:  2011-11-25       Impact factor: 5.048

View more
  65 in total

Review 1.  Immune-mediated cytokine storm and its role in severe dengue.

Authors:  Anon Srikiatkhachorn; Anuja Mathew; Alan L Rothman
Journal:  Semin Immunopathol       Date:  2017-04-11       Impact factor: 9.623

2.  Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus.

Authors:  Lalita Priyamvada; Kendra M Quicke; William H Hudson; Nattawat Onlamoon; Jaturong Sewatanon; Srilatha Edupuganti; Kovit Pattanapanyasat; Kulkanya Chokephaibulkit; Mark J Mulligan; Patrick C Wilson; Rafi Ahmed; Mehul S Suthar; Jens Wrammert
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-27       Impact factor: 11.205

Review 3.  Do Memory B Cells Form Secondary Germinal Centers? It Depends.

Authors:  Kathryn A Pape; Marc K Jenkins
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-01-02       Impact factor: 10.005

Review 4.  Basics of memory B-cell responses: lessons from and for the real world.

Authors:  Rachel Wong; Deepta Bhattacharya
Journal:  Immunology       Date:  2018-11-29       Impact factor: 7.397

Review 5.  Humanized mouse models to study human cell-mediated and humoral responses to dengue virus.

Authors:  Anuja Mathew
Journal:  Curr Opin Virol       Date:  2017-08-09       Impact factor: 7.090

6.  Dengue Virus Evades AAV-Mediated Neutralizing Antibody Prophylaxis in Rhesus Monkeys.

Authors:  Diogo M Magnani; Michael J Ricciardi; Varian K Bailey; Martin J Gutman; Núria Pedreño-Lopez; Cassia G T Silveira; Helen S Maxwell; Aline Domingues; Lucas Gonzalez-Nieto; Qin Su; Ruchi M Newman; Melissa Pack; Mauricio A Martins; José M Martinez-Navio; Sebastian P Fuchs; Eva G Rakasz; Todd M Allen; Stephen S Whitehead; Dennis R Burton; Guangping Gao; Ronald C Desrosiers; Esper G Kallas; David I Watkins
Journal:  Mol Ther       Date:  2017-07-24       Impact factor: 11.454

Review 7.  The Antibody-Secreting Cell Response to Infection: Kinetics and Clinical Applications.

Authors:  Michael J Carter; Ruth M Mitchell; Patrick M Meyer Sauteur; Dominic F Kelly; Johannes Trück
Journal:  Front Immunol       Date:  2017-06-01       Impact factor: 7.561

8.  Zika virus activates de novo and cross-reactive memory B cell responses in dengue-experienced donors.

Authors:  Thomas F Rogers; Eileen C Goodwin; Bryan Briney; Devin Sok; Nathan Beutler; Alexander Strubel; Rebecca Nedellec; Khoa Le; Michael E Brown; Dennis R Burton; Laura M Walker
Journal:  Sci Immunol       Date:  2017-08-18

9.  Arbovirus Diagnostics: From Bad to Worse due to Expanding Dengue Virus Vaccination and Zika Virus Epidemics.

Authors:  Graham Simmons; Mars Stone; Michael P Busch
Journal:  Clin Infect Dis       Date:  2018-04-03       Impact factor: 9.079

10.  Dynamics of Dengue Virus (DENV)-Specific B Cells in the Response to DENV Serotype 1 Infections, Using Flow Cytometry With Labeled Virions.

Authors:  Marcia Woda; Heather Friberg; Jeffrey R Currier; Anon Srikiatkhachorn; Louis R Macareo; Sharone Green; Richard G Jarman; Alan L Rothman; Anuja Mathew
Journal:  J Infect Dis       Date:  2016-07-20       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.